<DOC>
	<DOCNO>NCT01993030</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness HQ® Matrix Medical Wound Dressing repair donor site wound . Half participant receive HQ® Matrix Medical Wound Dressing , half receive Sidaiyi® wound dressing .</brief_summary>
	<brief_title>Evaluation HQ® Matrix Medical Wound Dressing Healing Donor Site Wounds</brief_title>
	<detailed_description>HQ® Matrix Medical Wound Dressing transparent , non-porous , pliable , gas-permeable , waterproof film dress comprise silk fibroin protein Bombyx mori ( B. mori ) silkworm . It intend provide moist , gas-permeable sterile environment facilitate normal wound heal process . It use management non-infected skin defect various dermal wound . Sidaiyi® wound dress ( Suzhou Soho Biomaterial Science Technology Co. , Ltd , Suzhou , China ) CFDA approve ( Su2012-2640182 ) , silk fibroin-based , two-layered spongy dressing . Upon silk fibroin spongy dress layer membrane make medical silicone . It use management partial- full-thickness wound , donor site wound burn . Currently , sole silk fibroin biomaterial wound heal receive regulatory approval worldwide .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<criteria>1 . Patients , age 18 60 , male female , wet wound burn , ulcerative skin soft tissue wound surface ; 2 . The wound surface area range 20cm^2 600cm^2 ; 3 . The patient clear mind misunderstand ; 4 . The patient voluntarily sign subject ' informed consent form receive timely followups . 1 . Patients active bleed wound surface ; 2 . Vasogenic disease : patient blood supply phlebothrombosis local wound tissue ; 3 . Those allergic silk material ; 4 . Those serious infection ; 5 . Those coagulation disorder ; 6 . Those tumor diabetes ; 7 . Patients , accord doctor ' opinion , unsuitable use material wound treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>